
April 21, 2014
Solving Cancer’s Secrets: 5 Questions with Dr. Chuck Perou
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
April 21, 2014
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
April 7, 2014
Science Magazine interviewed UNC Lineberger members Charles Perou, PhD, and James Evans, MD, PhD, for a special feature on “The ‘Other’ Breast Cancer Genes.”
April 7, 2014
Researchers at the UNC Lineberger Comprehensive Cancer Center and the University of Texas Southwestern Medical Center will investigate the role of proteins linked both to human sexual reproduction and cancer tumor formation thanks to a grant from the U.S. Department of Defense (DoD).
March 24, 2014
RNA encodes the proteins that play a key role in cellular reproduction, but the manner in which cells regulate its removal once these proteins are synthesized remains a mystery. One piece of this mystery has been solved as researchers at the University of North Carolina at Chapel Hill who have identified the steps by which a cell removes RNA from the cytoplasm.
February 11, 2014
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.
December 17, 2013
James Evans, MD, PhD, published his thoughts on the 23andMe genetic testing controversy in the Dec. 13 issue of The Cancer Letter.
November 27, 2013
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
November 1, 2013
UNC clinical geneticists Jonathan Berg and James Evans spearhead an ambitious project to catalog all genetic variations implicated in disease.
October 1, 2013
New test uses PAM50 breast cancer gene signature discovered by UNC’s Perou
December 6, 2011
CHAPEL HILL – The era of widely available next generation personal genomic testing has arrived and with it the ability to quickly and relatively affordably learn the sequence of your entire genome. This would include what is referred to as the “exome,” your complete set of protein-coding sequences.